Biodesix, Inc.
BDSX
$8.44
$0.303.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.29% | 25.70% | 35.76% | 45.30% | 48.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.29% | 25.70% | 35.76% | 45.30% | 48.92% |
| Cost of Revenue | 10.80% | 19.04% | 23.70% | 19.70% | 12.85% |
| Gross Profit | 25.58% | 27.63% | 39.51% | 54.53% | 63.93% |
| SG&A Expenses | 10.86% | 15.47% | 16.52% | 19.39% | 12.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.38% | 17.45% | 17.73% | 16.81% | 8.39% |
| Operating Income | 6.41% | -2.27% | 9.83% | 17.04% | 28.51% |
| Income Before Tax | 9.77% | 7.71% | 14.11% | 17.67% | 30.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.77% | 7.71% | 14.11% | 17.67% | 30.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.77% | 7.71% | 14.11% | 17.67% | 30.82% |
| EBIT | 6.41% | -2.27% | 9.83% | 17.04% | 28.51% |
| EBITDA | 9.04% | 1.66% | 16.78% | 24.97% | 35.11% |
| EPS Basic | 31.93% | 39.25% | 47.47% | 45.67% | 56.19% |
| Normalized Basic EPS | 31.70% | 39.09% | 48.05% | 46.23% | 52.96% |
| EPS Diluted | 31.93% | 39.25% | 47.47% | 45.67% | 56.19% |
| Normalized Diluted EPS | 31.70% | 39.09% | 48.05% | 46.23% | 52.96% |
| Average Basic Shares Outstanding | 27.40% | 47.87% | 62.96% | 57.55% | 57.58% |
| Average Diluted Shares Outstanding | 27.40% | 47.87% | 62.96% | 57.55% | 57.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |